🇺🇸 FDA
Patent

US 8440393

Pro-angiogenic genes in ovarian tumor endothelial cell isolates

granted A61PA61P35/00

Quick answer

US patent 8440393 (Pro-angiogenic genes in ovarian tumor endothelial cell isolates) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon May 09 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue May 14 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 09 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61P, A61P35/00